Efficacy and tolerability of brivaracetam in patients with intellectual disability and epilepsy

Ruby M. E. Gillis*, Elisabeth A. Wammes-van der Heijden, Helenius J. Schelhaas, In Y. Tan, Dederieke A. M. Festen, Marian H. J. M. Majoie

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)677-684
Number of pages8
JournalActa Neurologica Belgica
Volume121
Issue number3
Early online date10 Mar 2020
DOIs
Publication statusPublished - Jun 2021

Keywords

  • ADJUNCTIVE BRIVARACETAM
  • ADULT PATIENTS
  • Brivaracetam
  • DOUBLE-BLIND
  • Efficacy
  • Epilepsy
  • FOCAL EPILEPSY
  • Intellectual disability
  • PHASE-III
  • PREVALENCE
  • Side effects
  • GENERALIZED EPILEPSIES

Cite this